MyFinsight
Home
Blog
About
Contact
Download
Download image
Sale and maturity of
investment securities
$86,500K
Accrued liabilities
$23,557K
Stock-based compensation
$14,698K
Proceeds from issuance of
common stock, net of...
$4,231K
Interest and other
receivables
-$13,740K
Net income
$3,637K
Amortization of intangible
assets
$2,722K
Operating lease
right-of-use assets
-$2,164K
Accounts payable
$1,343K
Depreciation
$271K
Prepaid expenses
-$113K
Inventory
-$78K
Net cash provided by
(used in) investing...
$66,281K
Net cash provided by
operating activities
$33,981K
Net cash provided by
financing activities
$4,231K
Effect of exchange rate
changes on cash
$25K
Canceled cashflow
$20,219K
Canceled cashflow
$28,342K
Net increase
(decrease) in cash, cash...
$104,518K
Purchases of investment
securities
$15,007K
Purchases of property and
equipment
$5,212K
Accounts receivable, net
$13,893K
Long-term liabilities
-$6,500K
something is missing
-$5,187K
Operating lease
liabilities
-$2,183K
Amortization of premiums and
accretion of discounts on...
$453K
Deferred income taxes
-$94K
Other assets
$32K
Back
Back
Cash Flow
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)
source: myfinsight.com